Andrew Guggenhime Vaxcyte, Inc. (PCVX) insider trading activity

Andrew Guggenhime is PRESIDENT AND CFO of Vaxcyte, Inc.. Currently has a direct ownership of 124,309 shares of PCVX, which is worth approximately $6.01 Million. The most recent transaction as insider was on Dec 23, 2021, when has been sold 3,100 shares (Common Stock) at a price of $5.35 per share, resulting in proceeds of $16,585. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 124K

0% 3M change

13.53% 12M change

Total Value Held $6.01 Million

ANDREW GUGGENHIME Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 23 2021	BUY Exercise of conversion of derivative security	$16,585 $5.35 p/Share	3,100 Added 33.24%	6,225 Common Stock
Nov 18 2021	SELL Open market or private sale	$77,035 $24.85 p/Share	3,100 Reduced 49.8%	3,125 Common Stock
Nov 18 2021	BUY Exercise of conversion of derivative security	$16,585 $5.35 p/Share	3,100 Added 33.24%	6,225 Common Stock

Also insider at

MTCR

Metacrine, Inc. Healthcare

Director

CRBU

Caribou Biosciences, Inc. Healthcare

Director